- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Carcinoma, Ovarian Epithelial in United Kingdom
Total 14592 results
-
National Cancer Institute (NCI)CompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
University of OxfordAstraZenecaCompletedOvarian CancerUnited Kingdom
-
Fred Hutchinson Cancer CenterSwedish Medical CenterCompletedEpithelial Ovarian CancerUnited States
-
Genentech, Inc.TerminatedOvarian CancerUnited States, Spain, Belgium, Canada, France, United Kingdom, Poland
-
Women and Infants Hospital of Rhode IslandOrtho Biotech, Inc.Terminated
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompletedOvarian Cancer | Peritoneal Carcinoma | Tubal CarcinomaUnited States
-
Nektar TherapeuticsCompletedOvarian Cancer | TumorUnited States, Belgium, United Kingdom
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
Roswell Park Cancer InstituteCompletedFallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IIA Ovarian Cancer | Stage IIB Ovarian Cancer | Stage IIC Ovarian Cancer | Stage IIIA Ovarian Cancer | Stage IIIB Ovarian Cancer | Stage IIIC Ovarian Cancer | Stage IV Ovarian Cancer | Stage IA Ovarian Cancer | Stage IB Ovarian Cancer | Stage IC... and other conditionsUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
University of OklahomaGenentech, Inc.CompletedPrimary Peritoneal Carcinoma | Ovarian Carcinosarcoma | Advanced Ovarian CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Stage III Ovarian Epithelial Cancer | Stage III Ovarian Germ Cell TumorUnited States
-
MorphotekTerminatedEpithelial Ovarian CancerUnited States, Germany
-
Northwestern UniversityNational Cancer Institute (NCI); Ipsen BiopharmaceuticalsCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma | Refractory Fallopian Tube... and other conditionsUnited States
-
Oxford Vacmedix UK Ltd.RecruitingOvarian Cancer | Prostate Cancer | Non Small Cell Lung CancerUnited Kingdom
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
Cancer Research UKCompletedBreast Cancer | Ovarian Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited Kingdom
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Brenner Tumor | Stage II Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian... and other conditionsUnited States, Japan
-
University College, LondonAstraZeneca; Cancer Research UKCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited Kingdom
-
University of UtahWithdrawn
-
Glycotope GmbHCompletedFallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Epithelial Cancer RecurrentGermany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, United Kingdom
-
The University of Texas Health Science Center at...CompletedEpithelial Ovarian Cancer | Fallopian Tube Carcinoma | Extraovarian Peritoneal CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
Novartis PharmaceuticalsTerminatedRenal Cell Carcinoma | Epithelial Ovarian CancerJapan, Australia, Belgium, Spain, United States, Switzerland
-
Ira WinerRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Malignant Ovarian Epithelial Tumor | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)TerminatedOvarian CancerUnited States
-
Verastem, Inc.Terminated
-
Translational Research in OncologyCelgeneTerminatedEpithelial Ovarian CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Ovarian Carcinoma | Refractory Ovarian CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian CancerUnited States
-
Astex Pharmaceuticals, Inc.CompletedOvarian CancerCanada, United States, United Kingdom
-
NanOlogy, LLCUS Biotest, Inc.TerminatedOvarian CarcinomaUnited States
-
Institute of Cancer Research, United KingdomVerastem, Inc.Active, not recruitingPancreatic Cancer | NSCLC | Low Grade Serous Ovarian Cancer | Endometrioid CarcinomaUnited Kingdom
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
Cascadian Therapeutics Inc.Celldex TherapeuticsCompletedAdvanced Breast Carcinoma | Advanced Ovarian CarcinomaUnited States
-
Fred Hutchinson Cancer CenterFox Chase Cancer Center; City of Hope Medical Center; Stanford University; Cedars-Sinai... and other collaboratorsCompletedEpithelial Ovarian CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI); Medical Research Council; Southwest Oncology...CompletedPrimary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompleted
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedQuality of Life | Ovarian CancerUnited States
-
The University of Texas Health Science Center at...TerminatedEpithelial Ovarian Cancer | Fallopian Tube Carcinoma | Extraovarian Peritoneal CancerUnited States
-
Washington University School of MedicineCompletedFallopian Tube Cancer | Primary Peritoneal Carcinoma | Invasive Epithelial Ovarian CancerUnited States
-
Nuvectis Pharma, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...RecruitingOvarian Cancer | Ovarian Endometrioid Adenocarcinoma | Advanced Solid Tumor | Ovarian Clear Cell Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Clear Cell Tumor | Ovarian Endometrioid Tumor | ARID1A Gene MutationUnited States, United Kingdom
-
Prima BioMed LtdTerminatedEpithelial Ovarian CancerUnited States, Australia
-
MorphotekCompletedEpithelial Ovarian CancerUnited States
-
Icahn School of Medicine at Mount SinaiWithdrawn
-
University of ChicagoNational Cancer Institute (NCI)WithdrawnOvarian CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)Terminated
-
AstraZenecaMyriad Genetic Laboratories, Inc.WithdrawnPlatinum Sensitive Relapsed Ovarian CancerUnited States, Korea, Republic of, Peru, United Kingdom, Philippines